Wheels Up (UP) is a private aviation company that primarily serves the U.S. Credit Suisse initiated coverage of the stock with an outperform rating and a $14 price target. The next stock that George Tsilis discusses is ChemoCentryx (CCXI) as it soared today after the blood vessel inflammation drug, TAVNEOS received FDA approval. Raymond James raised its price target on the stock to $107 from $62. Finally, Aehr Test Systems (AEHR) makes test and burin-in equipment for us in the semiconductor industry. Craig-Hallum raised its price target on the stock to $31 from $12.